bharat biotech announces phase 3 results of covaxin, says it shows interim efficacy of 81%| breaking
Published 3 years ago • 6.1K plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
2:42
covaxin shows interim efficacy of 81% in phase 3 results: bharat biotech
-
3:41
bharat biotech announces successful phase-3 trial results of covaxin | made in india vaccine | wion
-
2:32
‘covaxin has 81% efficacy’: bharat biotech phase 3 trial results
-
3:36
bharat biotech phase 3 results | covaxin releases their interim analysis from phase three trials
-
1:05
bharat biotech concludes phase 3 trial of covaxin records 77.8% efficacy rate
-
1:58
bharat biotech says phase 3 results public by july | the news
-
25:46
serum institute, bharat biotech, cadila vaccines — sifting fact from fears, science from non-science
-
5:40
covaxin approval soon? who chief scientist says phase-3 trial data looks good | breaking news
-
3:06
81% interim clinical efficacy for bharat biotech’s made-in-india covid-19 vaccine, covaxin
-
3:40
covid-19 news: 70-80% decline in participants for phase3 trial of bharat biotech's covaxin
-
2:33
bharat biotech says covid-19 vaccine shows 81% interim efficacy
-
10:26
covid-19 vaccine: bharat biotech releases covaxin's phase 3 trial data, claims 77.8% efficacy
-
2:31
covaxin shows 77% efficacy in phase 3 trials, bharat biotech informs govt panel, data under review
-
7:47
covaxin interim results 'encouraging', phase 3 trials to continue: aiims chief
-
4:56
bharat biotech's covaxin shows 77.8% efficacy rate in phase 3 trial
-
9:37
bharat biotech’s covaxin shows 81% efficacy in phase 3 clinical trials
-
3:23
covaxin maker says it's 81% effective. what next?
-
2:54
bharat biotech releases covaxin's price ahead of india's phase 3 of vaccination | covid-19 vaccine
-
6:30
editorji newswrap: bharat biotech: covaxin showed 81% efficacy in phase 3 trials
-
2:14
bharat biotech announces covaxin's efficacy rate after final stage trials | covid-19 vaccine | news
-
0:40
bharat biotech's covaxin goes for who nod tomorrow | breaking news | india today
-
1:44
bharat biotech covaxin phase iii trial is approved by subject expert committee with 77.8% efficacy